13F HOLDINGS REPORT
SILVERARC CAPITAL MANAGEMENT, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001420506-23-001582
Total Value
$323.3M
Positions
82
Other Managers
1
Confidential Omitted
No
Holdings (82)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ImmunoGen Inc | 45253H101 | 1,420,000 | $26.8M | 8.29% |
| 2 | Merus NV | N5749R100 | 589,255 | $15.5M | 4.80% |
| 3 | Morphic Holding Inc | 61775R105 | 252,309 | $14.5M | 4.47% |
| 4 | Schrodinger Inc | SDGR | 286,169 | $14.3M | 4.42% |
| 5 | Krystal Biotech Inc | KRYS | 118,941 | $14.0M | 4.32% |
| 6 | Intra-Cellular Therapies Inc | 46116X101 | 198,723 | $12.6M | 3.89% |
| 7 | Akero Therapeutics Inc | 00973Y108 | 241,357 | $11.3M | 3.49% |
| 8 | Oric Pharmaceuticals Inc | ORIC | 1,450,822 | $11.3M | 3.48% |
| 9 | Akero Therapeutics Inc | 00973Y108 | 236,500 | $11.0M | 3.41% |
| 10 | MoonLake Immunotherapeutics | MLTX | 200,000 | $10.2M | 3.16% |
| 11 | Biogen Idec Inc | BIIB | 26,854 | $7.6M | 2.37% |
| 12 | 89bio Inc | 282559103 | 396,497 | $7.5M | 2.32% |
| 13 | Cogent Biosciences Inc | COGT | 620,000 | $7.3M | 2.27% |
| 14 | Aclaris Therapeutics Inc | ACRS | 651,400 | $6.8M | 2.09% |
| 15 | United Therapeutics Corp | UTHR | 30,029 | $6.6M | 2.05% |
| 16 | MacroGenics Inc | MGNX | 1,215,675 | $6.5M | 2.01% |
| 17 | KalVista Pharmaceuticals Inc | KALV | 720,508 | $6.5M | 2.01% |
| 18 | Veracyte Inc | VCYT | 229,451 | $5.8M | 1.81% |
| 19 | Mirati Therapeutics Inc | 60468T105 | 150,000 | $5.4M | 1.68% |
| 20 | BioCryst Pharmaceuticals Inc | BCRX | 760,904 | $5.4M | 1.66% |
| 21 | Terns Pharmaceuticals Inc | TERN | 599,668 | $5.2M | 1.62% |
| 22 | Poseida Therapeutics Inc | 73730P108 | 2,945,948 | $5.2M | 1.60% |
| 23 | Nuvalent Inc | NUVL | 115,067 | $4.9M | 1.50% |
| 24 | Gilead Sciences Inc | GILD | 60,448 | $4.7M | 1.44% |
| 25 | Vertex Pharmaceuticals Inc | VRTX | 13,175 | $4.6M | 1.43% |
| 26 | Tela Bio Inc | TELA | 416,440 | $4.2M | 1.30% |
| 27 | Viking Therapeutics Inc | VKTX | 258,595 | $4.2M | 1.30% |
| 28 | Praxis Precision Medicines Inc | PRAX | 3,476,162 | $4.0M | 1.24% |
| 29 | Xenon Pharmaceuticals Inc | XENE | 99,756 | $3.8M | 1.19% |
| 30 | Mersana Therapeutics Inc | 59045L106 | 1,100,000 | $3.6M | 1.12% |
| 31 | Olema Pharmaceuticals Inc | OLMA | 390,466 | $3.5M | 1.09% |
| 32 | Sarepta Therapeutics Inc | SRPT | 29,860 | $3.4M | 1.06% |
| 33 | Prothena Corporation PLC | PRTA | 49,721 | $3.4M | 1.05% |
| 34 | Mirati Therapeutics Inc | 60468T105 | 91,213 | $3.3M | 1.02% |
| 35 | Mersana Therapeutics Inc | 59045L106 | 1,000,000 | $3.3M | 1.02% |
| 36 | Insmed Inc | INSM | 144,464 | $3.0M | 0.94% |
| 37 | Pharvaris NV | PHVS | 200,000 | $3.0M | 0.94% |
| 38 | ANI Pharmaceuticals Inc | ANIP | 54,041 | $2.9M | 0.90% |
| 39 | Phathom Pharmaceuticals Inc | PHAT | 200,000 | $2.9M | 0.89% |
| 40 | Cerus Corp | CERS | 1,158,265 | $2.8M | 0.88% |
| 41 | Mirum Pharmaceuticals Inc | MIRM | 106,375 | $2.8M | 0.85% |
| 42 | Aclaris Therapeutics Inc | ACRS | 219,229 | $2.3M | 0.70% |
| 43 | Incyte Corp | INCY | 34,110 | $2.1M | 0.66% |
| 44 | Trevi Therapeutics Inc | TRVI | 885,924 | $2.1M | 0.65% |
| 45 | Intellia Therapeutics Inc | NTLA | 50,858 | $2.1M | 0.64% |
| 46 | Pliant Therapeutics Inc | PLRX | 107,267 | $1.9M | 0.60% |
| 47 | Rhythm Pharmaceuticals Inc | RYTM | 116,168 | $1.9M | 0.59% |
| 48 | CymaBay Therapeutics Inc | 23257D103 | 160,000 | $1.8M | 0.54% |
| 49 | Ambrx Biopharma Inc | 02290A102 | 100,000 | $1.6M | 0.51% |
| 50 | Cue Biopharma Inc | CUE | 403,402 | $1.5M | 0.46% |
| 51 | Eliem Therapeutics Inc | CLYM | 494,089 | $1.4M | 0.43% |
| 52 | Annexon Inc | ANNX | 389,911 | $1.4M | 0.42% |
| 53 | Zura Bio Ltd | ZURA | 160,000 | $1.3M | 0.41% |
| 54 | Reata Pharmaceuticals Inc | 75615P103 | 12,500 | $1.3M | 0.39% |
| 55 | Alkermes Plc | ALKS | 40,000 | $1.3M | 0.39% |
| 56 | Voyager Therapeutics Inc | VYGR | 100,000 | $1.1M | 0.35% |
| 57 | Viridian Therapeutics Inc | VRDN | 45,000 | $1.1M | 0.33% |
| 58 | Rezolute Inc | RZLT | 499,544 | $989,097 | 0.31% |
| 59 | Karyopharm Therapeutics Inc | KPTI | 518,985 | $928,983 | 0.29% |
| 60 | Allakos Inc | 01671P100 | 200,000 | $872,000 | 0.27% |
| 61 | BioMarin Pharmaceutical Inc | BMRN | 10,000 | $866,800 | 0.27% |
| 62 | Bridgebio Pharma Inc | BBIO | 50,000 | $860,000 | 0.27% |
| 63 | Point Biopharma Global Inc | 730541109 | 93,700 | $848,922 | 0.26% |
| 64 | Ventyx Biosciences Inc | 92332V107 | 25,000 | $820,000 | 0.25% |
| 65 | Protagonist Therapeutics Inc | PTGX | 25,000 | $690,500 | 0.21% |
| 66 | Jasper Therapeutics Inc | JSPRW | 500,000 | $685,000 | 0.21% |
| 67 | Aligos Therapeutics Inc | ALGS | 631,887 | $613,562 | 0.19% |
| 68 | Biohaven Ltd | BHVN | 20,000 | $478,400 | 0.15% |
| 69 | Syndax Pharmaceuticals Inc | SNDX | 20,000 | $418,600 | 0.13% |
| 70 | Compugen Ltd | CGEN | 330,188 | $376,414 | 0.12% |
| 71 | Immatics Nv | IMTX | 30,715 | $354,451 | 0.11% |
| 72 | Celldex Therapeutics Inc | CLDX | 10,000 | $339,300 | 0.10% |
| 73 | FibroGen Inc | 31572Q808 | 100,000 | $271,000 | 0.08% |
| 74 | Clene Inc | CLNN | 250,000 | $219,975 | 0.07% |
| 75 | Monte Rosa Therapeutics Inc | GLUE | 31,156 | $213,419 | 0.07% |
| 76 | Eloxx Pharmaceuticals Inc | ELOX | 54,075 | $210,352 | 0.07% |
| 77 | Pieris Pharmaceuticals Inc | 720795103 | 961,338 | $159,101 | 0.05% |
| 78 | Evogene Ltd | EVGN | 100,000 | $107,000 | 0.03% |
| 79 | Glaukos Corp | GKOS | 1,000 | $71,210 | 0.02% |
| 80 | Viewray Inc | 92672L107 | 100,000 | $35,220 | 0.01% |
| 81 | Rocket Pharmaceuticals Inc | RCKTW | 104,828 | $19,917 | 0.01% |
| 82 | Fresh Tracks Therapeutics Inc | 10802T204 | 10,000 | $7,013 | 0.00% |